The Problem
Cancer is usually detected in late stages
A vast majority of cancers show no symptoms until late stages, when treatment is complex, painful, traumatic, with poor clinical outcomes and high medical costs.
^ Diagnostic and treatment cost are estimates based on mapping of private hospital costs with cancer diagnostic & treatment pathways per stage of detection
India’s cancer reality
1 in 10 Indians will develop cancer during their lifetime
*Source: https://www.hindustantimes.com/india-news/one-in-10-indians-will-develop-cancer-during-their-lifetime-who/story-NcNQhPTS01YWI9Qovfcy5J.html
1 in 9 Indians will develop cancer during their lifetime
*Source: https://www.hindustantimes.com/lifestyle/health/cancer-risk-factors-here-s-why-indians-are-at-a-higher-risk-of-the-disease-101675603191553.html
Cancer is a global killer caused by the silent growth & invasion of malignant tumors across different organs of an individual’s body.
Cancer is a global killer caused by the silent growth & invasion of malignant tumors across different organs of an individual’s body.
In selected countries, regular screening examinations exist for only 6 (3%) out of more than 200 types of cancer known globally.
A large majority of the 1.4 million (per Globocan 2022) new cancer cases each year show up in late-stages (3,4) of cancer.
A large majority of the 1.4 million (per Globocan 2022) new cancer cases each year show up in late-stages (3,4) of cancer.
This huge cancer screening gap leads to late-stage detection which is associated with high death rate and high medical costs for payors of cancer treatment costs.
The Solution
Introducing multi-tumor screening blood test for asymptomatic healthy individuals
PanTum Detect screens healthy adults for dangerous tumors covering all solid cancers
Give life a chance
Introducing Cancer-Scan Program Initiated by pre-testing with PanTum Detect
Combines pre-testing and targeted follow-up cancer diagnostics only for those screened candidates that test positive with PanTum Detect blood test.
Innovative & Unique
The EDIM technology is backed by science and more than 20 years of research
Leveraging the immune system to deliver high accuracy of PanTum® Detect test
EDIM (Epitope Detected in Monocytes) Technology detects elevated levels of enzyme tumor biomarkers (Apo10 & TKTL-1) in macrophages. It leverages on our innate immune system, wherein macrophages do a biological biopsy and engulf universal enzyme tumor biomarkers (Apo10 & TKTL-1) when they phagocytose degenerated tumor cells.
Leveraging the immune system to deliver high accuracy of PanTum® Detect test
The human immune system is first to recognize the progression of disease, even before the onset of symptoms. EDIM® (Epitope Detection in Monocytes/Macrophages) technology makes the information contained in the human immune system visible for detection of cancer. Higher than normal levels of Apo10 (DNaseX) & TKTL1 detected in immune cells (macrophages) of screened individuals gives an indication of potential cancer and pre-cancer lesions in early and symptomless stages for healthy individuals.
Connect with us for any queries
Connect with us for any queries
Useful Links
Support
Locate Us
© 2023. All rights reserved